Rationale for using data on biological variation

Abstract The aims of this study are: 1) to use the data included in the biological variation (BV) database to address the usability of BV estimates; and 2) to use different examples from the authors’ laboratories to illustrate the use and the usefulness of BV data in laboratory medicine. The BV database is an essential tool for laboratory management. Examples of application of data derived from BV are given in this paper, such as analytical performance specifications that have been included in various quality control software designed to optimize operative rules; also they have been incorporated as acceptability limits in external quality assurance reports. BV data from pathological status are of utmost interest for monitoring patients and differences between the intra-individual coefficients of variation (CVI) estimated from healthy and patients are shown. However, for a number of analytes there are limited data available and for many there are no data, consequently new studies should be encouraged at an international level. In addition, developing international criteria to evaluate publications dealing with the estimation of BV components would be of the utmost interest. We are ready and willing to collaborate with such worthy initiatives. The first EFLM strategic conference on analytical performance specifications is an excellent opportunity for debating these ideas.

[1]  C. Fraser.  Making better use of differences in serial laboratory results , 2012, Annals of clinical biochemistry.

[2]  C. Fraser,et al.  Short-term biological variation of plasma analytes in renal disease. , 1983, Clinical Chemistry.

[3]  C G Fraser,et al.  Generation and application of data on biological variation in clinical chemistry. , 1989, Critical reviews in clinical laboratory sciences.

[4]  M. Plebani,et al.  Collective opinion paper on findings of the 2011 convocation of experts on laboratory quality , 2012, Clinical chemistry and laboratory medicine.

[5]  W. Hölzel.  Intra-individual variation of analytes in serum from patients with chronic liver diseases. , 1987, Clinical chemistry.

[6]  R. Macwalter,et al.  Biological variability of 26 clinical chemistry analytes in elderly people. , 1989, Clinical chemistry.

[7]  C. Fraser,et al.  Selecting the optimum specimen for assessing slight albuminuria, and a strategy for clinical investigation: novel uses of data on biological variation. , 1987, Clinical chemistry.

[8]  S. Skeie,et al.  Within-subject biological variation of glucose and HbA1c in healthy persons and in type 1 diabetes patients , 2011, Clinical chemistry and laboratory medicine.

[9]  T Yasaka,et al.  On the calculation of a "reference change" for comparing two consecutive measurements. , 1983, Clinical chemistry.

[10]  Jean-Claude Libeer,et al.  Proposals for Setting Generally Applicable Quality Goals Solely Based on Biology , 1997, Annals of clinical biochemistry.

[11]  Khosrow Adeli,et al.  Pediatric within-day biological variation and quality specifications for 38 biochemical markers in the CALIPER cohort. , 2014, Clinical chemistry.

[12]  Callum G. Fraser,et al.  Biological variation data are necessary prerequisites for objective autoverification of clinical laboratory data , 2002 .

[13]  J. Morancho,et al.  Minimum analytical quality specifications of inter-laboratory comparisons: agreement among Spanish EQAP organizers , 2011, Clinical chemistry and laboratory medicine.

[14]  B. Gould,et al.  Biological Variation in Glycated Proteins , 1993, Annals of clinical biochemistry.

[15]  M. Seibel,et al.  Long-term variability of bone turnover markers in patients with non-metastatic breast cancer. , 2002, Clinical laboratory.

[16]  Virtudes Alvarez,et al.  Within-subject biological variation in disease: collated data and clinical consequences , 2007, Annals of clinical biochemistry.

[17]  Callum G Fraser,et al.  Reference change values , 2012, Clinical chemistry and laboratory medicine.

[18]  G. Z. Williams,et al.  Individual character of variation in time-series studies of healthy people: II. Differences in values for clinical chemical analytes in serum among demographic groups, by age and sex. , 1978, Clinical chemistry.

[19]  R. Lauzurica,et al.  Reference change value concept combining two delta values to predict crises in renal posttransplantation. , 2001, Clinical chemistry.

[20]  R. Dittadi,et al.  Within-subject biological variation in disease: the case of tumour markers , 2008, Annals of clinical biochemistry.

[21]  L. Chambless,et al.  Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. , 1994, Archives of pathology & laboratory medicine.

[22]  M. Doménech,et al.  Determination of biological variation of α-fetoprotein and choriogonadotropin (β chain) in disease-free patients with testicular cancer , 2010, Clinical chemistry and laboratory medicine.

[23]  M Hørder,et al.  Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. , 1988, Scandinavian journal of clinical and laboratory investigation.

[24]  C. Frings,et al.  Improved colorimetric method for assay of amphetamines in urine. , 1971, Clinical chemistry.

[25]  C Ricós,et al.  Current databases on biological variation: pros, cons and progress. , 1999, Scandinavian journal of clinical and laboratory investigation.

[26]  J. Sundsfjord,et al.  Intra‐individual variability and longitudinal changes in glycaemic control in patients with Type 1 diabetes mellitus , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[27]  C Ricós,et al.  External quality assurance programs as a tool for verifying standardization of measurement procedures: Pilot collaboration in Europe. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[28]  A. Šimundić,et al.  Biological variation: a still evolving facet of laboratory medicine , 2015, Annals of clinical biochemistry.

[29]  Thomas P. Christensen.  The Clinical Laboratory Improvement Amendments of 1988. , 1989, Health Care Financing Review.

[30]  Carmen Perich,et al.  A category 1 EQA scheme for comparison of laboratory performance and method performance: An international pilot study in the framework of the Calibration 2000 project. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[31]  N. Guañabens,et al.  Components of biological variation of biochemical markers of bone turnover in Paget's bone disease. , 2000, Bone.

[32]  Callum G. Fraser,et al.  Biological Variation: From Principles to Practice , 2001 .

[33]  E. Erlandsen,et al.  Biological variation of cystatin C and creatinine , 2009, Scandinavian journal of clinical and laboratory investigation.

[34]  Carmen Ricós,et al.  Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality , 2011, Clinical chemistry and laboratory medicine.

[35]  S. Sandberg,et al.  Biological variation – reliable data is essential , 2015, Clinical chemistry and laboratory medicine.

[36]  R. Simó,et al.  Biological Variation of Lipoprotein(a) in a Diabetic Population. Analysis of the Causes and Clinical Implications , 2003, Clinical chemistry and laboratory medicine.

[37]  M. Bulsara,et al.  High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis , 2013, Clinical chemistry and laboratory medicine.

[38]  E. K. Harris,et al.  Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 3. Physiological and medical implications. , 1970, Clinical chemistry.

[39]  Virtudes Alvarez,et al.  Biological variation database: structure and criteria used for generation and update , 2015, Clinical chemistry and laboratory medicine.